NATIONAL HEALTHCARE CORP (NHC)
SIC breadcrumb: Services > SIC Major Group 80 > SIC 8051 Services-Skilled Nursing Care Facilities
SEC company page: https://www.sec.gov/edgar/browse/?CIK=1047335. Latest filing source: 0001437749-26-005910.
Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.
At a glance
- Revenue
- 1,517,781,000 USD verified
- Net income
- 120,015,000 USD verified
- Assets
- 1,526,419,000 USD verified
- Free cash flow
- 148,632,000 USD computed
- Net margin
- 7.91% computed
- Operating margin
- 8.46% computed
- Revenue YoY
- +16.09% computed
- ROE
- 11.23% computed
Peer & cluster context
Peer percentile fingerprint
Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 80 SIC Major Group 80, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.
Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
|---|---|---|---|---|
| Revenue | 1,517,781,000 | USD | 2025 | 2026-02-26 |
| Net income | 120,015,000 | USD | 2025 | 2026-02-26 |
| Assets | 1,526,419,000 | USD | 2025 | 2026-02-26 |
Financials
Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-26. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001047335.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 923,580,000 | 963,895,000 | 980,349,000 | 996,383,000 | 1,028,217,000 | 1,074,302,000 | 1,085,738,000 | 1,141,544,000 | 1,307,382,000 | 1,517,781,000 |
| Net income | 50,538,000 | 56,205,000 | 58,964,000 | 68,211,000 | 41,871,000 | 138,590,000 | 22,445,000 | 66,798,000 | 101,927,000 | 120,015,000 |
| Operating income | 60,542,000 | 54,110,000 | 56,076,000 | 49,038,000 | 48,155,000 | 50,925,000 | 31,896,000 | 57,458,000 | 89,895,000 | 128,352,000 |
| Diluted EPS | 3.32 | 3.69 | 3.87 | 4.44 | 2.72 | 8.99 | 1.45 | 4.34 | 6.53 | 7.67 |
| Operating cash flow | 90,882,000 | 94,466,000 | 98,435,000 | 100,103,000 | 203,259,000 | 62,394,000 | 8,742,000 | 111,216,000 | 107,303,000 | 185,078,000 |
| Capital expenditures | 62,601,000 | 32,347,000 | 29,772,000 | 26,400,000 | 21,873,000 | 39,399,000 | 30,200,000 | 27,901,000 | 27,600,000 | 36,446,000 |
| Dividends paid | 25,795,000 | 28,237,000 | 29,827,000 | 31,208,000 | 31,921,000 | 32,030,000 | 34,604,000 | 35,560,000 | 36,964,000 | 38,704,000 |
| Share buybacks | 8,195,000 | 0.00 | 867,000 | 872,000 | 53,000 | 836,000 | 9,903,000 | 2,482,000 | 13,502,000 | 14,730,000 |
| Assets | 1,087,447,000 | 1,096,526,000 | 1,080,948,000 | 1,286,648,000 | 1,362,132,000 | 1,403,396,000 | 1,275,450,000 | 1,310,796,000 | 1,524,429,000 | 1,526,419,000 |
| Liabilities | 417,836,000 | 393,094,000 | 346,491,000 | 507,579,000 | 563,872,000 | 494,936,000 | 397,936,000 | 400,316,000 | 541,266,000 | 451,904,000 |
| Stockholders' equity | 669,611,000 | 702,738,000 | 733,278,000 | 778,593,000 | 795,177,000 | 903,004,000 | 874,276,000 | 908,752,000 | 980,161,000 | 1,068,772,000 |
| Cash and cash equivalents | 26,335,000 | 59,118,000 | 43,247,000 | 50,334,000 | 147,093,000 | 107,607,000 | 58,667,000 | 107,076,000 | 76,121,000 | 92,829,000 |
| Free cash flow | 28,281,000 | 62,119,000 | 68,663,000 | 73,703,000 | 181,386,000 | 22,995,000 | -21,458,000 | 83,315,000 | 79,703,000 | 148,632,000 |
Ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 5.47% | 5.83% | 6.01% | 6.85% | 4.07% | 12.90% | 2.07% | 5.85% | 7.80% | 7.91% |
| Operating margin | 6.56% | 5.61% | 5.72% | 4.92% | 4.68% | 4.74% | 2.94% | 5.03% | 6.88% | 8.46% |
| Return on equity | 7.55% | 8.00% | 8.04% | 8.76% | 5.27% | 15.35% | 2.57% | 7.35% | 10.40% | 11.23% |
| Return on assets | 4.65% | 5.13% | 5.45% | 5.30% | 3.07% | 9.88% | 1.76% | 5.10% | 6.69% | 7.86% |
| Liabilities / equity | 0.62 | 0.56 | 0.47 | 0.65 | 0.71 | 0.55 | 0.46 | 0.44 | 0.55 | 0.42 |
| Current ratio | 1.93 | 2.12 | 2.04 | 1.75 | 1.62 | 1.62 | 1.79 | 1.89 | 1.81 | 1.82 |
Industry Peer Context
Net margin peer context
Operating margin peer context
ROE peer context
ROA peer context
Financial Bridges
Free cash flow = operating cash flow - capital expenditures
Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001437749-26-005910; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001437749-26-005910; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001437749-26-005910; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Financial Charts
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: Revenues. Source concepts: us-gaap:Revenues.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: PaymentsOfDividendsCommonStock. Source concepts: us-gaap:PaymentsOfDividendsCommonStock.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: Assets. Source concepts: us-gaap:Assets.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: Liabilities. Source concepts: us-gaap:Liabilities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
As-reported value updates
Quarterly
Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-06. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001047335.json.
| Quarter | End Date | Revenue | Net Income | Diluted EPS | Method |
|---|---|---|---|---|---|
| 2022-Q3 | 2022-09-30 | -0.16 | reported discrete quarter | ||
| 2023-Q1 | 2023-03-31 | 0.76 | reported discrete quarter | ||
| 2023-Q2 | 2023-06-30 | 1.06 | reported discrete quarter | ||
| 2023-Q3 | 2023-09-30 | 288,485,000 | 10,388,000 | 0.68 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 300,914,000 | 28,406,000 | derived Q4 = FY annual - nine-month YTD | |
| 2024-Q1 | 2024-03-31 | 297,176,000 | 26,213,000 | 1.69 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 300,658,000 | 26,844,000 | 1.73 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 340,198,000 | 42,789,000 | 2.73 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 369,350,000 | 6,081,000 | derived Q4 = FY annual - nine-month YTD | |
| 2025-Q1 | 2025-03-31 | 373,697,000 | 32,205,000 | 2.07 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 374,910,000 | 23,722,000 | 1.52 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 382,661,000 | 39,239,000 | 2.50 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 386,513,000 | 24,849,000 | derived Q4 = FY annual - nine-month YTD | |
| 2026-Q1 | 2026-03-31 | 381,821,000 | 35,857,000 | 2.27 | reported discrete quarter |
| 2026-Q2 | 2026-06-30 | 408,025,000 | 40,319,000 | 2.54 | reported discrete quarter |
Quarterly Charts
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-026199; filed 2026-08-06. Concept: Revenues. Source concepts: us-gaap:Revenues.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-026199; filed 2026-08-06. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-026199; filed 2026-08-06. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Business
Read NHC's verbatim Item 1 Business section from its latest 10-K: Business.
Risk Factors
Read NHC's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.
Latest quarter (10-Q)
Latest 10-Q source: 0001437749-26-026199.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
Forward–Looking Statements
References throughout this document to the Company include National HealthCare Corporation and its wholly owned subsidiaries. In accordance with the Securities and Exchange Commissions “Plain English” guidelines, this Quarterly Report on Form 10–Q has been written in the first person. In this document, the words “we”, “our”, “ours” and “us” refer only to National HealthCare Corporation and its wholly–owned subsidiaries and not any other person.
This Quarterly Report on Form 10–Q and other information we provide from time to time, contains certain “forward–looking” statements as that term is defined by the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations or cash flows, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, ability to control our patient care liability costs, ability to respond to changes in government regulations, ability to execute our three–year strategic plan, and similar statements including, without limitations, those containing words such as “believes”, “anticipates”, “expects”, “intends”, “estimates”, “plans”, and other similar expressions are forward–looking statements.
Forward–looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward–looking statements as a result of, but not limited to, the following factors:
| Column 1 | Column 2 |
|---|---|
| ● | national and local economic conditions, including their effect on the availability and cost of labor, utilities and materials; |
| Column 1 | Column 2 |
|---|---|
| ● | the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; |
| Column 1 | Column 2 |
|---|---|
| ● | changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries; |
| Column 1 | Column 2 |
|---|---|
| ● | liabilities and other claims asserted against us, including patient care liabilities, as well as the resolution of current litigation (see Note 17 to Interim Condensed Consolidated Financial Statements included in this Form 10-Q); |
| Column 1 | Column 2 |
|---|---|
| ● | the ability to attract and retain qualified personnel; |
| Column 1 | Column 2 |
|---|---|
| ● | the availability and terms of capital to fund acquisitions and capital improvements; |
29
Table of Contents
| Column 1 | Column 2 |
|---|---|
| ● | the competitive environment in which we operate; |
| Column 1 | Column 2 |
|---|---|
| ● | our need to make investments continually in our processes and information systems to protect the privacy of patients, partners and other persons and reduce the risk of successful cybersecurity attacks; |
| Column 1 | Column 2 |
|---|---|
| ● | damage to our reputation, regulatory penalties, legal claims and liability under state and federal laws that we could suffer upon any cybersecurity or privacy breaches; |
| Column 1 | Column 2 |
|---|---|
| ● | the ability to maintain and increase census levels; and |
| Column 1 | Column 2 |
|---|---|
| ● | demographic changes. |
See the notes to the quarterly financial statements, and “Item 1. Business” in our 2025 Annual Report on Form 10–K for a discussion of various governmental regulations and other operating factors relating to the healthcare industry and the risk factors inherent in them. This may be found on our web site at www.nhccare.com. You should carefully consider these risks before making any investment in the Company. These risks and uncertainties are not the only ones facing us. There may be additional risks that we do not presently know of or that we currently deem immaterial. If any of the risks occur, our business, financial condition or results of operations could be materially adversely affected. In that case, the trading price of our shares of stock could decline, and you may lose all or part of your investment. Given these risks and uncertainties, we can give no assurances that these forward–looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them.
Overview
National HealthCare Corporation (“NHC” or the “Company”) is a leading provider of senior health care services. As of June 30, 2026, we operate or manage, through certain affiliates, 80 skilled nursing facilities with a total of 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. We operate specialized care units within certain of our healthcare centers such as Alzheimer's disease care units and sub-acute nursing units. In addition, we provide insurance services, management and accounting services, and we lease properties to operators of skilled nursing and assisted living facilities. We operate in 9 states and are located primarily in the southeastern United States.
Summary of Goals and Areas of Focus
Occupancy
A primary area of management focus continues to be the rates of occupancy within our skilled nursing facilities. The overall census in owned and leased skilled nursing facilities for the three months ending June 30, 2026 was 90.1% compared to 89.4% for the same period a year ago. For the six months ended June 30, 2026, overall census in our owned and leased skilled nursing facilities was 90.0% compared to 89.3% for the same period a year ago.
30
Table of Contents
Due to America’s healthcare labor shortage, the challenge of maintaining desirable patient census levels has been amplified. Management has undertaken a number of steps in order to best position our current and future health care facilities. This includes working internally to examine and improve systems to be most responsive to referral sources and payors, as well as find creative initiatives to retain and attract qualified healthcare professionals. Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post–acute alliances to better position ourselves so we are an active participant in the delivery of post-acute healthcare services.
Quality of Patient Care
CMS introduced the Five-Star Quality Rating System to help consumers, their families and caregivers compare skilled nursing facilities more easily. The Five-Star Quality Rating System gives each skilled nursing operation a rating ranging between one and five stars in various categories (five stars being the best). The Company has always strived for patient-centered care and quality outcomes as precursors to outstanding financial performance.
The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of June 30, 2026:
| NHC Ratings | Industry Ratings | ||||||
|---|---|---|---|---|---|---|---|
| Total number of skilled nursing facilities, end of period | 80 | ||||||
| Number of 4 and 5-star rated skilled nursing facilities | 49 | ||||||
| Percentage of 4 and 5-star rated skilled nursing facilities | 61% | 40% | |||||
| Average rating for all skilled nursing facilities, end of period | 3.8 | 3.0 |
Development and Growth
We are undertaking to expand our senior care operations while protecting our existing operations and markets. The following table lists our recent development activities.
| Type of Operation | Description | Size | Location | Placed in Service | ||||
|---|---|---|---|---|---|---|---|---|
| Assisted Living Facility | New Operation | 79 units | Tullahoma, TN | Q2 2027 |
On June 1, 2026, the Company purchased the land, buildings, and other specified assets and assumed certain liabilities of five skilled nursing facilities from National Health Corporation (“National”) for a purchase price of $50,500,000. The operations have 639 licensed skilled nursing beds in the states of South Carolina and Tennessee.
On July 1, 2026, the Company purchased the land, facilities, and improvements of thirty-two skilled nursing facilities and three independent living facilities, currently leased by us as tenant, from National Health Investors (“NHI”) for a purchase price of $560,000,000. On the closing date of the transaction, the lease agreement with NHI is terminated. The Company currently operates and will continue to operate all of the facilities, except four Florida skilled nursing facilities. The four Florida skilled nursing facilities will continue to be subject to a third-party operator’s lease after the closing of the transaction.
We also have two multi-family developments that are currently under construction, both of which we are noncontrolling owners. These developments are located in Franklin, Tennessee and Hermitage, Tennessee with 332 units and 315 units, respectively. Our capital contributions in these developments are included in the line item "Investments in unconsolidated companies" in our interim condensed consolidated balance sheets.
Accrued Risk Reserves
Our accrued professional liability and workers’ compensation reserves totaled $121,129,000 at June 30, 2026 and are a primary area of management focus. We have set aside restricted cash and cash equivalents and marketable securities to fund our estimated professional liability and workers’ compensation liabilities.
As to exposure for professional liability claims, we have developed performance certification criteria to measure and bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents. Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction.
31
Table of Contents
Government Reimbursement Programs
Medicare – Skilled Nursing Facilities
In July 2025, CMS released its final rule outlining fiscal year 2026 Medicare payment rates and policy changes for skilled nursing facilities, which began on October 1, 2025. The fiscal year 2026 rule equates to a net 3.2% increase in Medicare Part A payments to SNFs in fiscal year 2026 compared to 2025 levels. The rule includes a market basket increase of 3.3%, an increase of 0.6% to the market basket forecast error adjustment, and a negative 0.7% productivity adjustment. These figures do not incorporate the SNF Value Based Purchasing (“VBP”) reduction for certain SNFs subject to the net reduction in payments under the SNF VBP; those adjustments are estimated to total $208.4 million in fiscal year 2026.
In July 2026, CMS released its final rule outlining fiscal year 2027 Medicare payment rates and policy changes for skilled nursing facilities, which will begin on October 1, 2026. The fiscal year 2027 proposal equates to a net 2.4% increase in Medicare Part A payments to SNFs in fiscal year 2027 compared to 2026 levels. The rule includes a market basket increase of 3.3% minus a 0.9% productivity adjustment. CMS also finalized its proposals related to the SNF Quality Reporting Program, including the removal of two measures related to COVID-19 vaccination, a shortened data reporting timeline, and the requirement to submit assessment data for all patients regardless of payer.
For the first six months of 2026, our average Medicare per diem rate for skilled nursing facilities incr
[Excerpt truncated for page length; source filing is linked above.]
Latest 10-K MD&A (excerpt)
Latest 10-K Item 7 source: 0001437749-26-005910. The complete FY 2025 MD&A is published at /company/NHC/mda/fy2025/.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
National HealthCare Corporation, which we also refer to as NHC or the Company, is a leading provider of post–acute care and senior health care services. At December 31, 2025, we operate or manage 80 skilled nursing facilities with 10,329 1icensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies located in 9 states. In addition, we provide management services, accounting and financial services, and insurance services to third party operators of healthcare properties. We also own the real estate of 10 healthcare properties and lease these properties to third party operators.
30
Executive Summary
Earnings
To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues. During certain inflationary times, our net patient revenues and government reimbursement may not keep pace with inflationary increases in our expenses, which may cause net earnings to decline.
Occupancy
A primary area of management focus continues to be the rates of occupancy within our skilled nursing facilities. The overall census (based on operational beds) in owned and leased skilled nursing facilities for 2025 was 89.7% compared to 88.6% in 2024 and 87.9% in 2023.
Due to America’s healthcare labor shortage, the challenge of maintaining desirable patient census levels has been amplified. Management has undertaken a number of steps in order to best position our current and future health care facilities. This includes working internally to examine and improve systems to be most responsive to referral sources and payors, as well as find creative initiatives to retain and attract qualified healthcare professionals. Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post–acute alliances to better position ourselves so we are an active participant in the delivery of post-acute healthcare services.
Quality of Patient Care
The Centers for Medicare and Medicaid Services (“CMS”) introduced the Five-Star Quality Rating System to help consumers, their families and caregivers compare skilled nursing facilities more easily. The Five-Star Quality Rating System gives each skilled nursing operation a rating ranging between one and five stars in various categories (five stars being the best). The Company has always strived for patient-centered care and quality outcomes as precursors to outstanding financial performance.
The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of December 31, 2025:
| NHC Ratings | Industry Ratings | ||||
|---|---|---|---|---|---|
| Total number of skilled nursing facilities, end of period | 80 | ||||
| Number of 4 and 5-star rated skilled nursing facilities | 50 | ||||
| Percentage of 4 and 5-star rated skilled nursing facilities | 62.5% | 38.6% | |||
| Average rating for all skilled nursing facilities, end of period | 3.83 | 2.95 |
Development and Growth
We are undertaking to expand our post–acute and senior health care operations while protecting our existing operations and markets. The following table lists our recent construction and purchase activities.
| Type of Operation | Description | Size | Location | Placed in Service |
|---|---|---|---|---|
| Hospice | New Agency | 1 agency | Cedar Bluff, VA | March 2023 |
| Skilled Nursing | Acquisition | 66 beds | Nashville, TN | May 2023 |
| Homecare | New Agency | 1 agency | Tallahassee, FL | May 2023 |
| Assisted Living Facility | New Operations | 135 units | Vero Beach, FL | July 2023 |
| Assisted Living Facility | New Operations | 95 units | Merritt Island, FL | July 2023 |
| Assisted Living Facility | New Operations | 100 units | Stuart, FL | July 2023 |
| Hospice | New Agency | 1 agency | Morristown, TN | April 2024 |
| Hospice | New Agency | 1 agency | Lawrenceburg, TN | July 2024 |
| Hospice | New Agency | 1 agency | Wytheville, VA | August 2024 |
| Hospice | New Agency | 1 agency | Clinton, TN | October 2024 |
On August 1, 2024, the Company purchased the assets of White Oak Management, Inc. (“White Oak”). The White Oak portfolio consisted of 15 skilled nursing facilities, two assisted living facilities, four independent living facilities and a long-term care pharmacy. The White Oak operations have 1,928 licensed skilled nursing beds, 48 assisted living units, and 302 independent living units in the states of South Carolina and North Carolina.
Accrued Risk Reserves
Our accrued professional liability and workers’ compensation reserves totaled $121,595,000 and $103,616,000 at December 31, 2025 and 2024, respectively, and are a primary area of management focus. We have set aside restricted cash and restricted marketable securities to fund our professional liability and workers’ compensation reserves.
As to exposure for professional liability claims, we have developed performance measures to bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents. Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction.
Segment Reporting
The Company has two reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and (2) homecare and hospice services. These reportable operating segments are consistent with information used by the Company’s Chief Executive Officer, as chief operating decision maker (“CODM”), to assess performance and allocate resources. The Company also reports an “all other” category that includes revenues from rental income, management and accounting services fees, insurance services, and costs of the corporate office.
The Company’s CODM evaluates performance including pretax earnings and allocates capital resources to each segment based on an operating model that is designed to improve the quality of patient care and profitability of the Company, while enhancing long-term shareholder value. The CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below.
31
The following tables set forth the Company’s consolidated statements of operations by business segment (in thousands):
| Year Ended December 31, 2025 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inpatient Services | Homecare and Hospice | All Other | Total | |||||||||||||
| Revenues: | ||||||||||||||||
| Net patient revenues | $ | 1,315,545 | $ | 154,086 | $ | – | $ | 1,469,631 | ||||||||
| Other revenues | 1,467 | – | 46,683 | 48,150 | ||||||||||||
| Net operating revenues | 1,317,012 | 154,086 | 46,683 | 1,517,781 | ||||||||||||
| Costs and Expenses: | ||||||||||||||||
| Salaries, wages and benefits | 775,477 | 93,535 | 52,068 | 921,080 | ||||||||||||
| Other operating | 336,746 | 27,537 | 12,919 | 377,202 | ||||||||||||
| Facility rent | 35,972 | 2,373 | 7,882 | 46,227 | ||||||||||||
| Depreciation and amortization | 41,066 | 581 | 3,273 | 44,920 | ||||||||||||
| Total costs and expenses | 1,189,261 | 124,026 | 76,142 | 1,389,429 | ||||||||||||
| Income (loss) from operations | 127,751 | 30,060 | (29,459 | ) | 128,352 | |||||||||||
| Non-operating income | – | – | 18,107 | 18,107 | ||||||||||||
| Interest expense | (6,371 | ) | – | – | (6,371 | ) | ||||||||||
| Unrealized gains on marketable equity securities | – | – | 22,344 | 22,344 | ||||||||||||
| Income before income taxes | $ | 121,380 | $ | 30,060 | $ | 10,992 | $ | 162,432 |
| Year Ended December 31, 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inpatient Services | Homecare and Hospice | All Other | Total | |||||||||||||
| Revenues: | ||||||||||||||||
| Net patient revenues | $ | 1,111,300 | $ | 140,459 | $ | – | $ | 1,251,759 | ||||||||
| Other revenues | 1,315 | – | 44,863 | 46,178 | ||||||||||||
| Government stimulus income | – | – | 9,445 | 9,445 | ||||||||||||
| Net operating revenues and stimulus income | 1,112,615 | 140,459 | 54,308 | 1,307,382 | ||||||||||||
| Costs and Expenses: | ||||||||||||||||
| Salaries, wages and benefits | 668,029 | 85,712 | 57,189 | 810,930 | ||||||||||||
| Other operating | 280,867 | 25,927 | 14,596 | 321,390 | ||||||||||||
| Facility rent | 33,787 | 2,295 | 7,100 | 43,182 | ||||||||||||
| Depreciation and amortization | 37,988 | 737 | 3,260 | 41,985 | ||||||||||||
| Total costs and expenses | 1,020,671 | 114,671 | 82,145 | 1,217,487 | ||||||||||||
| Income (loss) from operations | 91,944 | 25,788 | (27,837 | ) | 89,895 | |||||||||||
| Non-operating income | – | – | 19,690 | 19,690 | ||||||||||||
| Interest expense | (4,135 | ) | – | – | (4,135 | ) | ||||||||||
| Unrealized gains on marketable equity securities | – | – | 30,958 | 30,958 | ||||||||||||
| Income before income taxes | $ | 87,809 | $ | 25,788 | $ | 22,811 | $ | 136,408 |
32
| Year Ended December 31, 2023 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inpatient Services | Homecare and Hospice | All Other | Total | |||||||||||||
| Revenues: | ||||||||||||||||
| Net patient revenues | $ | 956,077 | $ | 131,537 | $ | – | $ | 1,087,614 | ||||||||
| Other revenues | 1,141 | – | 52,789 | 53,930 | ||||||||||||
| Net operating revenues | 957,218 | 131,537 | 52,789 | 1,141,544 | ||||||||||||
| Costs and Expenses: | ||||||||||||||||
| Salaries, wages and benefits | 589,279 | 80,610 | 42,455 | 712,344 | ||||||||||||
| Other operating | 254,559 | 23,529 | 10,095 | 288,183 | ||||||||||||
| Facility rent | 32,542 | 2,172 | 6,811 | 41,525 | ||||||||||||
| Depreciation and amortization | 38,172 | 786 | 3,076 | 42,034 | ||||||||||||
| Total costs and expenses | 914,552 | 107,097 | 62,437 | 1,084,086 | ||||||||||||
| Income (loss) from operations | 42,666 | 24,440 | (9,648 | ) | 57,458 | |||||||||||
| Non-operating income | – | – | 16,660 | 16,660 | ||||||||||||
| Interest expense | (324 | ) | – | – | (324 | ) | ||||||||||
| Unrealized gains on marketable equity securities | – | – | 14,944 | 14,944 | ||||||||||||
| Income before income taxes | $ | 42,342 | $ | 24,440 | $ | 21,956 | $ | 88,738 |
Results of Operations
The following table and discussion set forth items from the consolidated statements of operations as a percentage of net operating revenues and grant income for the years ended December 31, 2025, 2024 and 2023.
Percentage of Net Operating Revenues
[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]
MD&A history
Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.